SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-23-018118
Filing Date
2023-06-22
Accepted
2023-06-22 16:30:13
Documents
16
Period of Report
2023-06-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K arch20230622_8k.htm   iXBRL 8-K 30477
2 EXHIBIT 10.1 ex_536858.htm EX-10.1 18829
3 EXHIBIT 10.2 ex_536859.htm EX-10.2 19363
4 EXHIBIT 10.3 ex_536860.htm EX-10.3 19422
  Complete submission text file 0001437749-23-018118.txt   220125

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA arch-20230615.xsd EX-101.SCH 3409
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE arch-20230615_def.xml EX-101.DEF 10353
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE arch-20230615_lab.xml EX-101.LAB 13836
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arch-20230615_pre.xml EX-101.PRE 10348
10 EXTRACTED XBRL INSTANCE DOCUMENT arch20230622_8k_htm.xml XML 2322
Mailing Address 235 WALNUT STREET, SUITE 6 FRAMINGHAM MA 01702
Business Address 235 WALNUT STREET, SUITE 6 FRAMINGHAM MA 01702 617-431-2313
Arch Therapeutics, Inc. (Filer) CIK: 0001537561 (see all company filings)

IRS No.: 460524102 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 000-54986 | Film No.: 231033680
SIC: 3841 Surgical & Medical Instruments & Apparatus